Home » Topics » Regulatory

Regulatory
RSS

Lilly files NDA for new formulation of Prozac for depression

March 16, 2000

Swedish authorities issue first approval for next-generation PPI

March 15, 2000

Orphan Medical's Busulfex approved in Israel

March 15, 2000

Bioglan Pharma and Sakai to jointly develop ES-Gel aciclovir formulation

March 14, 2000

CE Mark granted for the Prosorba Column as rheumatoid arthritis Rx

March 14, 2000

FDA approval sought for Imitrex in the treatment of adolescent migraine

March 14, 2000

Curatek begins pivotal trial of clonidine gel for neuropathic pain

March 13, 2000

The FDA approves Viadur for once-yearly palliative treatment of advanced prostate cancer

March 10, 2000

New nondrug treatment approved for rheumatoid arthritis in Canada

March 10, 2000

New formulation of Agouron's Viracept approved in U.S.

March 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...